Citadel Embolization Device Study
B
Bradley N. Bohnstedt, MD
Primary Investigator
Administratively Closed
18 years - 80 years
All
Phase
N/A
150 participants needed
1 Location
Brief description of study
The purpose of this study is to gather preliminary safety and effectiveness data on Citadelbolization Device in the treatment of wide-neck intracranial aneurysms.
Detailed description of study
In this study, use of the Citadel Embolization Device will be limited to a population ofwith unruptured or ruptured wide-neck aneurysms who meet all study eligibility. The Citadel Embolization Device is intended to endovascularly obstruct or occlude
blood flow in intracranial aneurysms.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Unruptured Wide-neck Aneurysms
-
Age: 18 years - 80 years
-
Gender: All
Inclusion Criteria:
- Has a single, unruptured or ruptured target intracranial aneurysm that is suitable fordovascular treatment.
Exclusion Criteria:
1.Target aneurysm has been previously treated
Updated on
26 Jan 2026.
Study ID: SNEU-STRYKER-CITADEL, CDM10001448, 13720
